Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

CAMH neuroscientists develop novel protein peptide for targeted treatment of depression

Neuroscientists at the Centre for Addiction and Mental Health (CAMH) have developed a protein peptide that may be a novel type of highly targeted treatment for depression with a low side-effect profile. Depression affects one in ten Canadians at some time in their lives and is a leading cause of disability worldwide.

30 Nov 2010

Depressed and suicidal individuals linked to low levels of stress hormone cortisol

Depressed and suicidal individuals have low levels of the stress hormone cortisol in their blood and saliva. They also have substances in their spinal fluid that suggest there is increased inflammation in the brain. These findings could help to develop new methods for diagnosing and treating suicidal patients.

29 Nov 2010

Study indicates high self-rated lifetime prevalence of depression among psychiatrists

This study addresses depression and burn-out among a sample of psychiatrists collected at a professional congress. Within several constraints, the results indicate an high self-rated lifetime prevalence of depression of 41.6% among the sample. Also noteworthy is that a fifth (20.3%) of the sample showed evidence of acute depressive symptoms.

26 Nov 2010

UMDNJ researchers develop comprehensive strategy for recovery from smoking addiction

Researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ), following 10 years of studying tobacco use among smokers with mental illness, have developed a comprehensive strategy for recovery from smoking addiction that could serve as a nationwide model.

25 Nov 2010

Chronic high fat cholesterol diet may lead to Alzheimer's disease

Research from the Laboratory of Psychiatry and Experimental Alzheimers Research at the Medical University Innsbruck (Austria) demonstrated that chronic high fat cholesterol diet in rats exhibited pathologies similar to Alzheimer's disease. The results were published in Molecular Cellular Neuroscience with lead author Dr. Christian Humpel. The study was co-authored by PhD students, Celine Ullrich and Michael Pirchl, from the same Laboratory.

24 Nov 2010

USFDA grants Sun Pharma tentative marketing approval for generic Cymbalta

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Cymbalta®, duloxetine hydrochloride delayed-release capsules.

24 Nov 2010

Combination of caffeine and glucose can improve cognitive performance: Study

The combination of caffeine and glucose can improve the efficiency of brain activity, according to a recent study in which functional magnetic resonance imaging was used to identify the neural substrate for the combined effects of these two substances.

23 Nov 2010

Most patients taking anti-depressants give up treatment: Study

Most patients who take anti-depressants give up their treatment in less than six months, the minimum period recommended for treating severe depression and other derived pathologies. This is the conclusion of a new study carried out by Catalan researchers, which reveals that only 25% continue their treatment for more than 11 months.

23 Nov 2010

Researchers discover common genetic variants influence early puberty, body fat

Researchers at King's College London's Department of Twin Research have discovered, as part of a large international consortium, 30 new genes that control the age of sexual maturation in women, the Journal Nature Genetics publishes today.

22 Nov 2010

New treatment model to incorporate systematic depression screening at primary care visits

A treatment model designed to accommodate the beliefs and concerns of Chinese immigrants appears to significantly improve the recognition and treatment of major depression in this typically underserved group

20 Nov 2010

Ontario Brain Institute initiates new venture to help people with neurological disorders

Ontario took a major step to help the one million people in the province with neurological disorders and the 2.6 million Ontarians who will be affected by a neurological condition in their lifetime.

20 Nov 2010

Scientists identify gene variants associated with eating disorder

Scientists at The Children's Hospital of Philadelphia have identified both common and rare gene variants associated with the eating disorder anorexia nervosa.

20 Nov 2010

Researchers document novel form of splicing in nerve cell cytoplasm

Cells have their own version of the cut-and-paste editing function called splicing. Researchers at the University of Pennsylvania School of Medicine have documented a novel form of splicing in the cytoplasm of a nerve cell, which dictates a special form of a potassium channel protein in the outer membrane.

19 Nov 2010

Study compares effect on HT status in mid, late life on dementia risk

Compared to women never on hormone therapy, those taking hormone therapy only at midlife had a 26 percent decreased risk of dementia; while women taking HT only in late life had a 48 percent increased risk of dementia, according to Kaiser Permanente researchers.

19 Nov 2010

Experts formulate research related to psychological adjustment and traumatic brain injury

Five U.S. federal agencies recently cosponsored a set of expert work groups to formulate common data elements for research related to psychological adjustment and traumatic brain injury (TBI).

19 Nov 2010

ProvenCare to focus on potential problems in lung cancer patients

Northwestern Memorial Hospital is one of six national participants in a pilot study that will test whether operable lung cancer patients and their families have a smoother care experience and better outcomes by hardwiring data systems to reduce medical error and to reliably adhere to best practice standards.

19 Nov 2010

Neural differences may help explain prevalence of mental disorders in boys

Many mental health disorders, such as autism and schizophrenia, produce changes in social behavior or interactions. The frequency and/or severity of these disorders is substantially greater in boys than girls, but the biological basis for this difference between the two sexes is unknown.

18 Nov 2010

Naurex's antidepressant shares efficacy mechanisms with NMDA receptor antagonist ketamine

Naurex Inc., a company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported that data presented at Neuroscience 2010 show that GLYX-13, its clinical-stage candidate for the treatment of depression, shares key mechanistic features associated with the antidepressant efficacy of the NMDA receptor antagonist ketamine.

18 Nov 2010

Sun Pharma receives FDA approval for generic Tiazac ANDA

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of once-a-day Tiazac® extended release capsules.

18 Nov 2010

FDA approves Sun Pharma's generic Clarinex ANDA

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted it an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Schering Plough's Clarinex® tablets, 5 mg.

18 Nov 2010

Psychiatry News and Research

Further Reading

CAMH neuroscientists develop novel protein peptide for targeted treatment of depression

Depressed and suicidal individuals linked to low levels of stress hormone cortisol

Study indicates high self-rated lifetime prevalence of depression among psychiatrists

UMDNJ researchers develop comprehensive strategy for recovery from smoking addiction

Chronic high fat cholesterol diet may lead to Alzheimer's disease

USFDA grants Sun Pharma tentative marketing approval for generic Cymbalta

Combination of caffeine and glucose can improve cognitive performance: Study

Most patients taking anti-depressants give up treatment: Study

Researchers discover common genetic variants influence early puberty, body fat

New treatment model to incorporate systematic depression screening at primary care visits

Ontario Brain Institute initiates new venture to help people with neurological disorders

Scientists identify gene variants associated with eating disorder

Researchers document novel form of splicing in nerve cell cytoplasm

Study compares effect on HT status in mid, late life on dementia risk

Experts formulate research related to psychological adjustment and traumatic brain injury

ProvenCare to focus on potential problems in lung cancer patients

Neural differences may help explain prevalence of mental disorders in boys

Naurex's antidepressant shares efficacy mechanisms with NMDA receptor antagonist ketamine

Sun Pharma receives FDA approval for generic Tiazac ANDA

FDA approves Sun Pharma's generic Clarinex ANDA

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News